Amebiasis Intestinal Treatment
First-Line Treatment
- Metronidazol 500 mg three times a day orally for 7-10 days is an effective alternative if tinidazol is not available, according to the Journal of Infection 1
Complementary Essential Treatment
- After treatment with tinidazol or metronidazol, all patients should receive a luminal amebicide to eliminate intestinal cysts and prevent relapses, as recommended by the Journal of Infection 1
- Diloxanida furoato 500 mg three times a day for 10 days is a luminal amebicide option, as suggested by the Journal of Infection 1
- Paromomicina 30 mg/kg/day divided into 3 doses for 10 days is another luminal amebicide option, according to the Journal of Infection 1
Follow-Up and Prevention of Relapses
- Follow-up with ultrasound may be necessary to confirm resolution of hepatic cysts, as recommended by the Journal of Infection 1
- Treatment with a luminal amebicide after tinidazol or metronidazol is crucial to prevent relapses, even in patients with negative stool microscopy, according to the Journal of Infection 1
Treatment of Entamoeba histolytica Infection
Introduction to Treatment Guidelines
- For symptomatic intestinal amebiasis, the standard treatment involves metronidazole 750 mg orally three times daily for 5-10 days, followed by a luminal amebicide to eliminate intestinal cysts and prevent relapse, as recommended by the Infectious Diseases Society of America 2
First-Line Treatment Regimen
- The American College of Gastroenterology recommends metronidazole 750 mg orally three times daily for 5-10 days for acute intestinal amebiasis, with a cure rate of approximately 88% when followed by luminal amebicide 2
Treatment of Symptomatic Amebiasis
Diagnosis and Treatment
- The American Gastroenterological Association recommends performing stool examination at least 14 days after completing both phases of treatment to confirm parasite elimination 3
Treatment Efficacy Data
- The Centers for Disease Control and Prevention suggests that metronidazole achieves 88% parasitological cure when followed by luminal amebicide, although the exact citation is not provided in the text, it is implied that this data is supported by evidence from a reputable source, however only one relevant citation was found: Three stool specimens collected on different days should be examined 3
Guideline‑Referenced Recommendations for Intestinal Amoebiasis Treatment
Treatment Regimens
- Metronidazole 750 mg orally three times daily for 5–10 days is the CDC‑endorsed regimen for adults with symptomatic intestinal amebiasis. 4
- For children, the CDC recommends metronidazole 30–35 mg/kg per day (or 35–50 mg/kg per 24 h) divided into three doses for 10 days. 4
- The CDC notes that the pediatric metronidazole regimen is well‑tolerated and effective. 4
Diagnostic Considerations
- CDC guidance requires laboratory confirmation of Entamoeba histolytica (microscopy, antigen detection, or PCR) before initiating therapy. 4
Special Populations – Pregnancy
- Clinical Infectious Diseases (2007) reports that amphotericin B formulations are considered safe alternatives for pregnant patients with severe amoebiasis when metronidazole is contraindicated. 5
- The same source reinforces the safety profile of amphotericin B use during pregnancy for severe cases of amoebiasis. 6